» Articles » PMID: 39342369

Sequential Release of Vancomycin and BMP-2 from Chitosan/nano-hydroxyapatite Thermosensitive Hydrogel for the Treatment of Chronic Osteomyelitis

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2024 Sep 28
PMID 39342369
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we developed scaffolds materials with microspheres to form a double sustained release system.Chitosan/nano-hydroxyapatite (CS-HA) was used as a drug carrier to construct a sustained-release system for Bone morphogenetic protein-2(BMP-2) and Vancomycin (VAN). Furthermore, VAN and BMP-2 loaded microspheres (Ms) were prepared by the emulsion ultrasonic method.The resultant composites were characterized by Scanning electron microscope (SEM), compressive strength, porosity, and biodegradation. The characterization results showed uniform porous and rough surface, enhanced thermal stability, and highest compressive strength ((1.912 ± 0.012) Kpa, the surface of the two microspheres was slightly folded and showed a regular spherical shape.The loading rate of BMP-2 was (59.611 × 10 ± 0.023 × 10)% and the encapsulation rate was (6.022 ± 0.005)%. The release rate of vancomycin and BMP-2 was 57.194% and 12.968% respectively. Osteogenic differentiation of Bone marrow mesenchymal stem cells (BMSCs) was confirmed by alkaline phosphatase quantification. The deposition of late osteogenic markers (calcium phosphates) detected by Alizarin red, which indicated extracellular matrix mineralization. The results showed that BMP-2/VAN in CS-HA hydrogel successfully achieved the sequential release of the double drugs, which could benefit bone regeneration.

Citing Articles

Treatment of chronic osteomyelitis with gradient release of DGEA and vancomycin hydrogel-microsphere system and its mechanism.

Zheng Y, Wang Y, Sheng F, Wang S, Zhou Y, Li X Front Pharmacol. 2024; 15:1499742.

PMID: 39588147 PMC: 11586164. DOI: 10.3389/fphar.2024.1499742.

References
1.
Liu X, Chen Y, Huang Q, He W, Feng Q, Yu B . A novel thermo-sensitive hydrogel based on thiolated chitosan/hydroxyapatite/beta-glycerophosphate. Carbohydr Polym. 2014; 110:62-9. DOI: 10.1016/j.carbpol.2014.03.065. View

2.
Fu C, Yang X, Tan S, Song L . Enhancing Cell Proliferation and Osteogenic Differentiation of MC3T3-E1 Pre-osteoblasts by BMP-2 Delivery in Graphene Oxide-Incorporated PLGA/HA Biodegradable Microcarriers. Sci Rep. 2017; 7(1):12549. PMC: 5624967. DOI: 10.1038/s41598-017-12935-x. View

3.
Lari A, Esmaeil A, Marples M, Watts A, Pincher B, Sharma H . Single versus two-stage management of long-bone chronic osteomyelitis in adults: a systematic review and meta-analysis. J Orthop Surg Res. 2024; 19(1):351. PMC: 11177413. DOI: 10.1186/s13018-024-04832-7. View

4.
Beenken K, Smith J, Skinner R, McLaren S, Bellamy W, Gruenwald M . Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis. J Biomater Appl. 2014; 29(4):514-23. PMC: 4264383. DOI: 10.1177/0885328214535452. View

5.
Peric Kacarevic Z, Rider P, Alkildani S, Retnasingh S, Pejakic M, Schnettler R . An introduction to bone tissue engineering. Int J Artif Organs. 2019; 43(2):69-86. DOI: 10.1177/0391398819876286. View